Biotech Firm May Bring 250 Jobs To Phoenix, Arizona

Phoenix beat out San Diego, San Francisco and Seattle as the new headquarters for a Canadian biotech firm that also is considering building a protein manufacturing plant in the Valley. InNexus Biotechnology Inc., which develops drugs from naturally occurring proteins, is consolidating operations and moving to Phoenix to conduct clinical trials for its cancer and heart drugs. Ultimately, the company could employ as many as 250 people here. Plans call for taking an initial 15,000 square feet within Mayo Clinic's 110,000-square-foot research complex at 136th Street and Shea Boulevard in Scottsdale. Written into the 10-year lease are plans for expansion. About 40 people will be employed at that lab to begin with, but as the company expands, as many as 100 will work there, said Jeff Morhet, InNexus chief operating officer.

Back to news